Kronos Bio announces workforce reduction of 83% by year-end
PremiumThe FlyKronos Bio announces workforce reduction of 83% by year-end
4M ago
Kronos Bio Restructures Workforce and Leadership
Premium
Company Announcements
Kronos Bio Restructures Workforce and Leadership
4M ago
Kronos Bio to present preclinical data from p300 KAT inhibitor program
Premium
The Fly
Kronos Bio to present preclinical data from p300 KAT inhibitor program
5M ago
Kronos Bio reports Q3 EPS (23c), consensus (28c)
PremiumThe FlyKronos Bio reports Q3 EPS (23c), consensus (28c)
5M ago
Kronos Bio files $250M mixed securities shelf
Premium
The Fly
Kronos Bio files $250M mixed securities shelf
5M ago
Kronos Bio to present data at ASH annual meeting on p300 KAT inhibitor program
Premium
The Fly
Kronos Bio to present data at ASH annual meeting on p300 KAT inhibitor program
5M ago
Kronos Bio to present preclinical data from p300 KAT inhibitor program
PremiumThe FlyKronos Bio to present preclinical data from p300 KAT inhibitor program
6M ago
Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium
Premium
The Fly
Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium
6M ago
Kronos Bio reports Q2 EPS (27c), consensus (34c)
Premium
The Fly
Kronos Bio reports Q2 EPS (27c), consensus (34c)
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100